Core Laboratories NVCLB

CLB current price
$19.74+7.34%

Capital at risk.

1W
-0.15%
1M
-2.81%
3M
+11.09%
6M
+6.46%
1Y
+7.34%
MAX
-81.33%
Calendar
event
Ex dividend date
04 Nov 2024
event_available
Last Dividend Payment
25 Nov 2024
About Core Laboratories NV
Ticker
info
CLB
Trading on
info
NYSE
ISIN
info
US21867A1051
Industry
info
Oil & Gas Equipment & Services
Sector
info
Energy
CEO
info
Lawrence V. Bruno
Headquarters
info
6316 Windfern Road, Houston, TX, United States, 77040
Employees
info
3,500
Website
info
corelab.com
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Metrics
BasicAdvanced
Market cap
info
$952M
P/E ratio
info
37.25
EPS
info
$0.53
Dividend Yield
info
0.20%
Beta
info
2.36
Forward P/E ratio
info
21.55
EBIDTA
info
$71.4M
Ex dividend date
info
2024-11-04
Price & volume
Market cap
info
$952M
Average daily volume
info
0.2M
90-day return
info
11.09%
30-day return
info
-2.81%
7-day return
info
-0.15%
Dividends
Dividend per share
info
$0.04
Dividend yield
info
0.20%
Forward dividend per share
info
$0.04
Forward dividend yield
info
0.20%
Payout ratio
info
4.71%
Valuation
P/E ratio
info
37.25
Forward P/E
info
21.55
PEG ratio
info
1.81
Trailing P/E
info
37.25
Price to sales
info
1.82
Price to book
info
3.8
Earnings
EPS
info
$0.53
EPS estimate (current quarter)
info
$0.23
EPS estimate (next quarter)
info
$0.25
EBITDA
info
$71.4M
Revenues (TTM)
info
$523M
Revenues per share (TTM)
info
$11.16
Technicals
Beta
info
2.36
52-week High
info
$25.11
52-week Low
info
$13.80
50-day moving average
info
$19.68
200-day moving average
info
$18.79
Short ratio
info
23.15
Short %
info
26.80%
Management effectiveness
ROE (TTM)
info
11.16%
ROA (TTM)
info
5.89%
Profit margin
info
5.01%
Gross profit margin
info
$96.1M
Operating margin
info
12.35%
Growth
Quarterly earnings growth (YoY)
info
31.60%
Quarterly revenue growth (YoY)
info
7.20%
Share stats
Outstanding Shares
info
47M
Float
info
46.5M
Insiders %
info
0.86%
Institutions %
info
112.67%
Analyst Insights & forecasts
info

15% Buy

57% Hold

28% Sell

Based on information from 7 analysts.

Average price target

info
$19.33
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.19
$0.19
-
Q4 • 23Beat
$0.19
$0.16
18.75%
Q1 • 24Beat
$0.22
$0.21
4.76%
Q2 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$131M
$9M
6.92%
Q2 • 24
$134M
$11.7M
8.74%
Q3 • 24
2.93%
30.04%
26.34%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$598M
$352M
58.90%
Q2 • 24
$600M
$344M
57.30%
Q3 • 24
0.45%
2.29%
2.72%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$17.1M
$-0.7M
$-13.6M
$14.2M
Q2 • 24
$13.6M
$-0.5M
$-9.2M
$10.4M
Q3 • 24
20.49%
28.53%
32.56%
27.03%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.75

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Core Laboratories NV share?
Collapse

Core Laboratories NV shares are currently traded for $19.74 per share.

How many shares does Core Laboratories NV have?
Collapse

Core Laboratories NV currently has 47M shares.

Does Core Laboratories NV pay dividends?
Collapse

Yes, Core Laboratories NV does pay dividends.

What is Core Laboratories NV 52 week high?
Collapse

Core Laboratories NV 52 week high is $25.11.

What is Core Laboratories NV 52 week low?
Collapse

Core Laboratories NV 52 week low is $13.80.

What is the 200-day moving average of Core Laboratories NV?
Collapse

Core Laboratories NV 200-day moving average is $18.79.

Who is Core Laboratories NV CEO?
Collapse

The CEO of Core Laboratories NV is Lawrence V. Bruno.

How many employees Core Laboratories NV has?
Collapse

Core Laboratories NV has 3,500 employees.

What is the market cap of Core Laboratories NV?
Collapse

The market cap of Core Laboratories NV is $952M.

What is the P/E of Core Laboratories NV?
Collapse

The current P/E of Core Laboratories NV is 37.25.

What is the EPS of Core Laboratories NV?
Collapse

The EPS of Core Laboratories NV is $0.53.

What is the PEG Ratio of Core Laboratories NV?
Collapse

The PEG Ration of Core Laboratories NV is 1.81.

What do analysts say about Core Laboratories NV?
Collapse

According to the analysts Core Laboratories NV is considered a hold.